Belladonna

Belladonna is an FDA drug label for the active ingredient BELLADONNA manufactured by Energique, Inc. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231219.

Generic: BELLADONNA

Manufacturer: Energique, Inc.

Product Type: HUMAN OTC DRUG

Route: ORAL

Dosage Form:

NDC: 44911-0381

Application:

Effective: 20231219

Active Ingredients: ACTIVE INGREDIENT: (in each drop): 100% of Belladonna 200C.

Indications & Usage

INDICATIONS: May temporarily relieve sudden flushes of heat or fever, especially with red face.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Dosage & Administration

DIRECTIONS: Adults and children 5 to 10 drops orally, 1 time daily or as otherwise directed by a health care professional. If symptoms persist for more than 3 days, consult your health care professional. Consult a physician for use in children under 12 years of age.

Contraindications

Not available.

Warnings

WARNINGS: If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.

Adverse Reactions